Patents by Inventor John Duncan Elliott

John Duncan Elliott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endothelin receptor antagonists
    Patent number: 6051599
    Abstract: Novel furans and thiophenes, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonist are described.
    Type: Grant
    Filed: September 20, 1999
    Date of Patent: April 18, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Aiming Gao
  • Endothelin receptor antagonists
    Patent number: 6030970
    Abstract: Novel to isooxazoles, oxazoles, thiazoles, isothiazoles and imidazoles, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: February 2, 1998
    Date of Patent: February 29, 2000
    Assignee: Smithkline Beecham Corporation
    Inventors: John Duncan Elliott, Juan Ignacio Luengo, Jia-Ning Xiang
  • Endothelin receptor antagonists
    Patent number: 6022886
    Abstract: Novel pyrroles, pyrazoles and triazoles, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: February 8, 2000
    Assignee: SmithKline Beecham Corporation
    Inventor: John Duncan Elliott
  • Endothelin receptor antagonists
    Patent number: 6020348
    Abstract: Novel pyridines, pyrimidines, pyrazines, pyridazines and triazines, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: February 1, 2000
    Assignee: SmithKline Beecham Corporation
    Inventor: John Duncan Elliott
  • Endothelin receptor antagonists
    Patent number: 6017952
    Abstract: This invention relates to derivatives of furan and thiophene, their composition, process of making and method of use as endothelin receptor antagonists.
    Type: Grant
    Filed: February 2, 1998
    Date of Patent: January 25, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Aiming Gao, Jia-Ning Xiang
  • Endothelin receptor antagonists
    Patent number: 5985886
    Abstract: Novel indane and indene derivatives are described which are endothelin receptor antagonists.
    Type: Grant
    Filed: June 16, 1998
    Date of Patent: November 16, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Deborah Lynne Bryan
  • Endothelin receptor antagonists
    Patent number: 5968971
    Abstract: Novel furans and thiophenes, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: October 19, 1999
    Assignee: SmithKline Beecham Corporation
    Inventor: John Duncan Elliott
  • Endothelin receptor antagonists
    Patent number: 5969151
    Abstract: This is a continuation of application Ser. No. 08/718,562, filed Sep. 30, 1996, which is a 371 of International Application No. PCT/US96/12581, filed Aug. 2, 1996; which claims the benefit of priority from the following provisional applications: 60/001,792, filed Aug. 2 1995 and 60/010,982, filed Feb. 1, 1996.
    Type: Grant
    Filed: July 23, 1998
    Date of Patent: October 19, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: Juan Ignacio Luengo, John Duncan Elliott
  • Endothelin receptor antagonists
    Patent number: 5958968
    Abstract: Novel pyrroles, pyrazoles and triazoles, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: September 28, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: Juan Ignacio Luengo, John Duncan Elliott
  • Endothelin receptor antagonists
    Patent number: 5942516
    Abstract: Novel pyridines, pyrimidines, pyrazines, pyridazines and triazines, pharmaceutical compositions containing these compounds and their use as endothelin receptor antagonists are described.
    Type: Grant
    Filed: September 27, 1996
    Date of Patent: August 24, 1999
    Inventors: John Duncan Elliott, Deborah Lynne Bryan
  • Apparatus and process for arraying beads
    Patent number: 5935859
    Abstract: A mixture of beads from a combinatorial library is held in suspension either by inducing circulating flow of a liquid in a tapered vessel by rising air bubbles or by floating the beads at the interface between two immiscible liquids. Beads are selected individually from the suspension by drawing liquid into the tip of a needle having a circular opening smaller than the diameter of a bead. After a bead is captured on the tip of a needle, excess beads are jarred loose or washed away by flow of a solvent through a sheath surrounding the needle, and the needle is moved by a robotic manipulator to a well into which the bead is released.
    Type: Grant
    Filed: July 29, 1998
    Date of Patent: August 10, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, John Gerald Gleason, Jack Dale Leber, Gerald C. Simolike
  • Cyclopentene derivatives as endothelin receptor antagonists
    Patent number: 5929116
    Abstract: Novel cyclopentane derivatives are described which are endothelin receptor antagonists.
    Type: Grant
    Filed: October 13, 1995
    Date of Patent: July 27, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Deborah Lynne Bryan
  • Endothelin receptor antagonists
    Patent number: 5929106
    Abstract: Dihydroisoindole compounds of formula (I), wherein the substituents are as defined herein, are disclosed as being useful as endothelin receptor antagonists. The compounds are applied in the treatment of cardiovascular and renal diseases.
    Type: Grant
    Filed: October 27, 1997
    Date of Patent: July 27, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Robert Gene Franz, M. Amparo Lago, Aiming Gao
  • Endothelin receptor antagonists
    Patent number: 5834469
    Abstract: The invention concerns compounds of the following formulae: ##STR1## wherein the variables are defined in the specification. The compounds are useful as endothelin receptor antagonists.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 10, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Jack Dale Leber
  • Endothelin receptor antagonists
    Patent number: 5817653
    Abstract: Novel compounds of the formula: ##STR1## are disicosed which are endothelin receptor antagonists.
    Type: Grant
    Filed: April 12, 1996
    Date of Patent: October 6, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, John Gerald Gleason, David Taylor Hill
  • Endothelin receptor antagonists
    Patent number: 5817693
    Abstract: Novel indane and indene derivatives are described which are endothelin receptor antagonists.
    Type: Grant
    Filed: November 9, 1994
    Date of Patent: October 6, 1998
    Inventors: Russell Donovan Cousins, John Duncan Elliott, Maria Amparo Lago, Jack Dale Leber, Catherine Elizabeth Peishoff
  • Endothelin receptor antagonists
    Patent number: 5817683
    Abstract: Naphthoic derivatives of the Formula (I) ##STR1## wherein the variables are defined herein; and pharmaceutical compositions containing these compounds, and their use as endothelin receptor antagonists are disclosed.
    Type: Grant
    Filed: April 8, 1996
    Date of Patent: October 6, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Jia-Ning Xiang
  • Endothelin receptor antagonists
    Patent number: 5736564
    Abstract: The present invention relates to dihydroisoindole compounds, pharmaceutical compositions containing these compounds, and their use as endothelin receptor antagonists.
    Type: Grant
    Filed: December 12, 1996
    Date of Patent: April 7, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Robert Gene Franz, M. Amparo Lago, Aiming Gao
  • Endothelin receptor antagonists
    Patent number: 5719183
    Abstract: Novel indane and indene derivatives are described which are endothelin receptor antagonists.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: February 17, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: Russell Donovan Cousins, John Duncan Elliott, Maria Amparo Lago, Jack Dale Leber, Catherine Elizabeth Peishoff
  • Endothelin receptor anatagonists
    Patent number: 5719182
    Abstract: Novel indane and indene derivatives are described which are endothelin receptor antagonists.
    Type: Grant
    Filed: May 16, 1995
    Date of Patent: February 17, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: Russell Donovan Cousins, John Duncan Elliott, Maria Amparo Lago, Jack Dale Leber, Catherine Elizabeth Peishoff